Metraipolis › archive › dc_ce8249d83c7a
Biomaterial engineering of the tumor glycocalyx for cancer immunotherapy — Europe PMC PMID:42764979
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42764979
- DOI
- 10.1016/j.mtbio.2026.103664
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-10T05:05:07.180Z
- SHA-256 of the archived text
4e05483662372616dec8798fad76f9028891143b598f4f32eb6ff046145890f2- Stable URL of this page
https://metraipolis.com/documento/dc_ce8249d83c7a
How to cite
Biomaterial engineering of the tumor glycocalyx for cancer immunotherapy — Europe PMC PMID:42764979 — Europe PMC (en), https://europepmc.org/article/MED/42764979 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ce8249d83c7a (Metraipolis archive dc_ce8249d83c7a, sha256 4e05483662372616dec8798fad76f9028891143b598f4f32eb6ff046145890f2)
BibTeX
@misc{dcce8249d83c7a,
title = {Biomaterial engineering of the tumor glycocalyx for cancer immunotherapy — Europe PMC PMID:42764979},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42764979},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ce8249d83c7a; sha256 4e05483662372616dec8798fad76f9028891143b598f4f32eb6ff046145890f2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42764979. Agents can read the archived copy with the MCP tool read_document.